GGrantIndex
Sort

23,748 grants matching melanoma

The CD93 pathway and melanoma therapy

$355,706
Yuwen Zhu · University Of Colorado Denver · R01 · FY2025 · CA

Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts

$355,706
Yinsheng Wang · University Of California Riverside · R01 · FY2020 · CA

The CD93 pathway and melanoma therapy

$355,706
Yuwen Zhu · University Of Colorado Denver · R01 · FY2022 · CA

Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts

$355,706
Yinsheng Wang · University Of California Riverside · R01 · FY2021 · CA

Impact of Melanoma Genetic Testing on Health Cognitions and Prevention Behaviors

$355,697
Lisa G Aspinwall · University Of Utah · R01 · FY2015 · CA

Southwest Oncology Group

$355,660
Loyola University Chicago · U10 · FY2004 · CA

Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts

$355,612
Yinsheng Wang · University Of California Riverside · R01 · FY2018 · CA

Novel Conformal Iodine-125 Ophthalmic Plaques

$355,578
Implant Sciences Corporation · R44 · FY2003 · CA

Glycobiology of Human Medulloblastoma

$355,524
Stephan Ladisch · Children'S Research Institute · R01 · FY2006 · CA

Cellular and molecular regulators of melanocyte regeneration

$355,520
Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AR

TOTAL SYNTHESES OF INDOLE ALKALOIDS

$355,518
University Of Vermont &St Agric College · R01 · FY2002 · CA

Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition

$355,489
Eduardo Davila · University Of Colorado Denver · R01 · FY2019 · CA

Design of de novo interleukin mimics for targeted immunotherapy

$355,489
David Baker · University Of Washington · R01 · FY2019 · CA

DNA and protein reactions of NO', ONOO-, and reactive species produced by phagocy

$355,406
Peter C Dedon · Massachusetts Institute Of Technology · P01 · FY2012 · CA

Safety and Efficacy of Vemurafenib and High-Dose InterferonAlpha-2b for Advanced Melanoma

$355,405
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2018 · CA

Biological Imaging Core

$355,332
Johannes Czernin · California Institute Of Technology · P01 · FY2010 · CA

Novel Approaches for Pancreatic Cancer Therapy

$355,239
Paul B Fisher · Columbia University Health Sciences · R01 · FY2006 · CA

Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition

$355,237
Eduardo Davila · University Of Maryland Baltimore · R01 · FY2018 · CA

Multiplex matrix ELISA for T cell protein-interaction networks in cancer

$355,217
Adam G. Schrum · University Of Missouri-Columbia · R33 · FY2019 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP STUDIES

$355,170
Case Western Reserve University · U10 · FY2001 · CA

Immunotherapy for Skin Cancer Precursors to Prevent Skin Cancer

$355,165
Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2020 · AR

Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis

$355,096
Benjamin Izar · Columbia University Health Sciences · U54 · FY2025 · CA

Fgl-2 targeted therapy for reversing multi-modality immune suppression

$355,019
Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$355,019
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Merkel cell polyomavirus infection, DNA damage response and cancer

$355,019
Jianxin You · University Of Pennsylvania · R01 · FY2019 · CA